Silence Therapeutics plc
SLNCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $205,468 | $226,714 | $160,097 | $364,918 |
| - Cash | $82,031 | $41,739 | $64,886 | $121,330 |
| + Debt | -$182 | $0 | $60 | $117 |
| Enterprise Value | $123,255 | $184,975 | $95,271 | $243,705 |
| Revenue | $159 | $224 | $142 | $24,328 |
| % Growth | -29% | 57.7% | -99.4% | – |
| Gross Profit | $95 | $139 | $88 | $22,722 |
| % Margin | 59.7% | 62.1% | 62% | 93.4% |
| EBITDA | -$26,088 | -$22,491 | -$19,810 | $7,193 |
| % Margin | -16,407.5% | -10,040.6% | -13,950.7% | 29.6% |
| Net Income | -$20,958 | -$27,354 | -$28,530 | $14,174 |
| % Margin | -13,181.1% | -12,211.6% | -20,091.5% | 58.3% |
| EPS Diluted | -0.15 | -0.19 | -0.2 | 0.1 |
| % Growth | 21.1% | 5% | -300% | – |
| Operating Cash Flow | -$10,891 | -$21,784 | -$12,309 | -$24,864 |
| Capital Expenditures | $52 | -$48 | -$4 | -$56 |
| Free Cash Flow | -$10,839 | -$21,832 | -$12,313 | -$24,920 |